In today’s biotech landscape, innovation doesn’t stop at the molecule. The most valuable IP now lives in how discoveries are made, the data, the algorithms, and the collaborative platforms that drive them. In our latest article, we explore how growth-stage biotech companies can: • Leverage licensing as a monetization and risk-sharing engine • Build strategic collaborations that amplify reach and accelerate growth • Design platform IP strategies that protect not just one molecule, but the entire innovation ecosystem A strong IP framework does more than protect assets — it positions your company for long-term resilience and strategic partnerships. Read the full article: https://lnkd.in/e3RfbBYJ #HyltonRodicLaw #IntellectualProperty #LifeSciences #BiotechLaw #PharmaInnovation #Licensing #Collaboration #PlatformStrategy #PatentLaw #Commercialization
Hylton-Rodic Law
Legal Services
Washington, District of Columbia 309 followers
Intellectual Property Law Across Industries Biotech . Chemical . Medical Devices . Pharmaceutical
About us
Hylton-Rodic Law is an intellectual property law firm working collaboratively with our clients to provide personalized legal representation of the highest quality that is responsive, cost-effective, and efficient. All of our attorneys have strong scientific backgrounds and the ability to focus on legal issues while knowing how to navigate complicated technical problems. Our clients run the gamut from start-ups to large multinational companies. Hylton-Rodic Law provides a wide range of intellectual property services, including patent procurement, patent portfolio development and management, patent-related risk assessment, trade secrets, trademarks, and IP licensing across industries - Biotechnology, Pharmaceuticals, Consumer Goods, and Chemicals.
- Website
-
http://www.hyltonrodiclaw.com
External link for Hylton-Rodic Law
- Industry
- Legal Services
- Company size
- 2-10 employees
- Headquarters
- Washington, District of Columbia
- Type
- Privately Held
- Founded
- 2015
- Specialties
- Biotech, Freedom-to-Operate (FTO), Patent, Chemistry, Pharmaceuticals, Food Science, Polymers, Biotechnology, Intellectual Property, Patent Procurement, Intellectual Property Law, and IP Law
Locations
-
Primary
Get directions
700 12th St NW
Suite 700
Washington, District of Columbia 20005, US
Employees at Hylton-Rodic Law
Updates
-
We're #hiring a new Associate Patent Attorney (1-2 years – Life Sciences / Chemical) in Washington DC-Baltimore Area. Apply today or share this post with your network.
-
Hylton-Rodic Law reposted this
WE’RE HIRING in Washington, D.C. Hylton-Rodic Law PLLC is growing and we’re looking for IP talent to support our life sciences and chemical patent practice. 📌 Open roles: Experienced IP Paralegal (Full-Time) 👉 Apply through the link https://lnkd.in/ehDmGXnr 2nd Year Associate Patent Attorney (Life Sciences / Chemical) (Full-Time) 👉 Apply through the link https://lnkd.in/eAD2RAcE If you have experience in biomedical, biochemical, or chemistry fields and want to work with an IP firm serving innovative clients, we’d love to hear from you. #Hiring #PatentLaw #IntellectualProperty #LifeSciences #Biotech #WashingtonDC
-
-
WE’RE HIRING in Washington, D.C. Hylton-Rodic Law PLLC is growing and we’re looking for IP talent to support our life sciences and chemical patent practice. 📌 Open roles: Experienced IP Paralegal (Full-Time) 👉 Apply through the link https://lnkd.in/ehDmGXnr 2nd Year Associate Patent Attorney (Life Sciences / Chemical) (Full-Time) 👉 Apply through the link https://lnkd.in/eAD2RAcE If you have experience in biomedical, biochemical, or chemistry fields and want to work with an IP firm serving innovative clients, we’d love to hear from you. #Hiring #PatentLaw #IntellectualProperty #LifeSciences #Biotech #WashingtonDC
-
-
Your biotech patent could be undone by the same AI that helped create it. AI-generated prior art is flooding the system, often unverifiable, inaccessible, and legally questionable. Know the difference between valid disclosures and synthetic noise before they block your IP. Read the blog to learn how to safeguard your filings. - https://lnkd.in/eDj7yGaP #BiotechIP #AIinLaw #PharmaPatents #PatentStrategy #InnovationRisk #SyntheticPriorArt
-
-
Happy Paralegal Appreciation Day! Today, we shine the spotlight on the heart of our legal engine, our extraordinary paralegals. Whether coordinating filings, navigating complex documentation, or supporting client strategy with speed and precision, our paralegals are essential to everything we do at Hylton‑Rodic Law. They work behind the scenes, but their impact is front and center. To our own team and to paralegals everywhere: thank you for your precision, professionalism, and dedication to justice. 📣 Know a rockstar paralegal? Tag them and let them know they’re appreciated! #ParalegalAppreciationDay #LegalSupportMatters #HyltonRodicLaw #TeamHRL #ParalegalPride #LawFirmLife #LegalProfessionals
-
-
Read more about what Keisha Hylton-Rodic had to share from her time in Munich at the Life Sciences Strategy Summit on IP & Exclusivity, where collaboration, innovation, and insight took center stage. 🔗 https://lnkd.in/eKQp2pDa #LifeSciences #IPStrategy #PatentLaw #ThoughtLeadership #LSSummit2025 #HyltonRodicLaw
-
-
New blog posted! The patent cliff is ending, but that doesn’t mean your IP protections should. Discover how to build an IP ecosystem that withstands patent expirations and powers new growth. 🔗 Read more: https://lnkd.in/ew6Hk5XJ #PharmaceuticalIP #BiotechInnovation #PatentCliff #LifeSciencesLaw #DrugExclusivity #IntellectualPropertyStrategy #TradeSecrets #RegulatoryExclusivity #PharmaLicensing #BiotechPatents
-
-
Hylton-Rodic Law reposted this
What a session! 🙌 The kind of conversation that reminds me why I love this work — nuance, challenge, and collaboration all rolled into one. A huge thank you to Ina Bürck, Julia Pike, Mathilde Rauline, and Dr. Maurizio Di Stasio for such a robust and insightful discussion on Divisional Patenting in Europe and the USA: How Can Originators and Generics Navigate the Current Legal Landscape? We were just getting warmed up when time ran out — always the best sign of sharp minds and lively debate in the room! 🔥 Special shoutout to Aaron White, Duncan Henderson, and Fred Grumitt for keeping the wheels turning behind the scenes 🚍🛠️ — the unsung heroes who make great conversations possible. As this space continues to evolve, one thing’s clear: the dialogue between originators and generics isn’t just about competition — it’s about coexistence, innovation, and finding smarter ways to serve patients and protect progress. Always a pleasure to share space with brilliant colleagues shaping the future of life sciences IP strategy. 🚀 💬 Loved hearing everyone’s take on balancing protection vs. access. There’s no “one size fits all,” but collaboration gets us closer. #LSStrategySummit #LifeSciences #IPStrategy #KisacoResearch #PatentLaw #LSSummit2025
-
-
Honoured to see our founder representing Hylton Rodic Law at the Life Sciences Strategy Summit in Munich, sharing insights on SPCs and exclusivity with a distinguished international panel. 📌 Catch her key insights below.
Turning Molecules into Monopolies™ | Patent Strategist-In-Chief in a Chem/Pharma Attorney’s Disguise | Growth-Driven IP Counsel
Humbling to be in the same room here in Munich with a panel of Examiners from France, Germany, Ireland, Netherlands and the UK and listening to them speaking on Patent Office Panel Session: Understand Legal Perspectives on the Most Pressing SPC Topics at Life Sciences Strategy Summit on IP & Exclusivity https://lnkd.in/ezsntNSQ. Just a reminder that we are truly one village.
-